Latest filing published 04 Mar 2020 for Parallax Health Sciences, INC., €89k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Calli Bucci: trading record in brief
This profile gathers the share dealings of Calli Bucci in Parallax Health Sciences, Inc. We count 3 filings; the first trade dates from 5 April 2018 and the latest from 31 December 2019.
No open-market sale appears; the market trades are 3 purchases worth €185k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2020 alone, the filings show 1 purchase and no sales.
The median purchase comes to €89k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 4 March 2020: an open-market purchase of €89k, in Parallax Health Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 50 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Calli Bucci
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$0.0549.3% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000020:0Canonical exit: 30 Mar 2020 (T+90)
- 1,600,000 shares@ US$0.062550.7% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000153:0Canonical exit: 29 Dec 2019 (T+90)
- 5,000,000 shares@ US$0.0012.2% of flowCOMMON STOCKSEC:0001388410-18-000009:0Canonical exit: 4 Jul 2018 (T+90)
3 of 3 declarations
